NCT06282991 2026-03-10
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
Completed
Clinical Trials
4 trialsNCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT04753658 2024-09-23
Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib
Pfizer
Terminated
NCT04647110 2023-04-06
Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.
Pfizer
Completed